Off-label or unapproved drug use and physicians' expectations of life insurance companies

被引：0

作者：

Higuchi, Yukiko ^{[1
,2
]}

Koseki, Hiroshi

Watanabe, Naoki ^{[1
]}

Nonoda, Megumi ^{[3
]}

Hirate, Kazunari ^{[3
]}

Iwata, Takuya ^{[3
]}

Funao, Tomomi ^{[3
]}

Nakahara, Shinsuke ^{[3
]}

Sato, Tsunehiro ^{[3
]}

Kato, Daisaku ^{[1
]}

Honjo, Yukio ^{[3
]}

Katumata, Noriyuki ^{[4
]}

机构：

[1] Meiji Yasuda Res Inst Inc, Tokyo, Japan

[2] Hirosaki Univ, Grad Sch Med, Dept Social Med, Hirosaki, Aomori, Japan

[3] Meiji Yasuda Life Insurance Co, Tokyo, Japan

[4] Musashi Kosugi Hosp, Dept Med Oncol, Nippon Med Sch, Kawasaki, Kanagawa, Japan

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.163

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MO5-4

引用

页码：S1398 / S1398

页数：1

共 50 条

[1] Unapproved and off-label use of drugs in a children's hospital
'T Jong, GW
Vulto, AG
de Hoog, M
Schimmel, KJM
Tibboel, D
van den Anker, JN
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (15): : 1125 - 1125
[2] Abatacept/cyclophosphamideLack of efficacy and off-label use in unapproved indication
Reactions Weekly, 2024, 2006 (1) : 13 - 13
[3] Off-label and unapproved pediatric drug utilization: A meta-analysis
Yuan, Xingxing
Gao, Jiawei
Yang, Liuxin
Tan, Yurong
Bajinka, Ousman
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2024, 28 (05)
[4] Azithromycin/hydroxychloroquine/steroidsLack of efficacy and off-label use in an unapproved indication
Reactions Weekly, 2024, 2014 (1) : 104 - 104
[5] FDA is criticised for poor oversight of drug companies' promotion of off-label drug use
Tanne, Janice Hopkins
BMJ-BRITISH MEDICAL JOURNAL, 2008, 337 (7665):
[6] Off-label use of medicine: Perspective of physicians, patients, pharmaceutical companies and regulatory authorities
Gupta, Sandeep Kumar
Nayak, Roopa Prasad
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2014, 5 (02) : 88 - 92
[7] Baricitinib/dexamethasone/remdesivirLack of efficacy and off-label use in unapproved indication
Reactions Weekly, 2024, 1999 (1) : 81 - 81
[8] Dapsone/dupilumabMethaemoglobinaemia and off-label use in unapproved indication: case report
Reactions Weekly, 2023, 1986 (1) : 161 - 161
[9] MethylprednisoloneLack of efficacy and off-label use in unapproved indication: case report
Reactions Weekly, 2024, 2021 (1) : 303 - 303
[10] DISSEMINATION OF INFORMATION ON THE OFF-LABEL (UNAPPROVED) USE OF MEDICATION: A COMPARATIVE ANALYSIS
Jansen, Rita-Marie
MEDICINE AND LAW, 2011, 30 (01): : 115 - 132

← 1 2 3 4 5 →